Sources | Names Used |
---|---|
CTRPv2 | SNX-2112:bortezomib (250:1 mol/mol) |
PharmacoGx | SNX-2112:bortezomib (250:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SEC63 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
mRNA | FBXO46 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
mRNA | GGT7 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
mRNA | RHBDD2 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
mRNA | OAZ1 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
mRNA | CTD-2349B8.1 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
mRNA | PPIH | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
mRNA | LMAN2 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
mRNA | TMX1 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
mRNA | NPAS2 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |